Steven Cohen's GH Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 102,415 shares of Guardant Health, Inc. (GH) worth $6.4 M, representing 0.01% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in GH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 2.54 M shares. Largest reduction occurred in Q3 2023, reducing 2.65 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2019 | +4,672 | New Buy | 4,672 | $76.63 |
| Q2 2019 | +909 | Add 19.46% | 5,581 | $86.36 |
| Q3 2019 | +759,442 | Add 13607.63% | 765,023 | $63.83 |
| Q4 2019 | -670,377 | Reduce 87.63% | 94,646 | $78.14 |
| Q1 2020 | -94,646 | Sold Out | 94,646 | $0.00 |
| Q3 2020 | +191,216 | New Buy | 191,216 | $111.78 |
| Q4 2020 | -154,856 | Reduce 80.98% | 36,360 | $128.88 |
| Q1 2021 | -36,360 | Sold Out | 36,360 | $0.00 |
| Q2 2021 | +93,596 | New Buy | 93,596 | $124.19 |
| Q3 2021 | -93,596 | Sold Out | 93,596 | $0.00 |
| Q4 2021 | +82,100 | New Buy | 82,100 | $100.02 |
| Q1 2022 | -82,100 | Sold Out | 82,100 | $0.00 |
| Q3 2022 | +178,942 | New Buy | 178,942 | $53.83 |
| Q4 2022 | -178,942 | Sold Out | 178,942 | $0.00 |
| Q2 2023 | +2.71 M | New Buy | 2.71 M | $35.80 |
| Q3 2023 | -2.65 M | Reduce 97.76% | 60,879 | $29.64 |
| Q4 2023 | -60,879 | Sold Out | 60,879 | $0.00 |
| Q1 2024 | +1.43 M | New Buy | 1.43 M | $20.63 |
| Q2 2024 | +388,603 | Add 27.24% | 1.82 M | $28.88 |
| Q3 2024 | -1.82 M | Sold Out | 1.82 M | $0.00 |
| Q4 2024 | +873,082 | New Buy | 873,082 | $30.55 |
| Q1 2025 | -96,512 | Reduce 11.05% | 776,570 | $42.60 |
| Q2 2025 | -720,270 | Reduce 92.75% | 56,300 | $52.04 |
| Q3 2025 | +46,115 | Add 81.91% | 102,415 | $62.48 |
Steven Cohen's Guardant Health Investment FAQs
Steven Cohen first purchased Guardant Health, Inc. (GH) in Q1 2019, acquiring 4,672 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Guardant Health, Inc. (GH) for 27 quarters since Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Guardant Health, Inc. (GH) was in Q2 2023, adding 2,714,285 shares worth $97.17 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 102,415 shares of Guardant Health, Inc. (GH), valued at approximately $6.4 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Guardant Health, Inc. (GH) was 2,714,285 shares, as reported at the end of Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.